TWiV 922: TWiV clinical update with Dr. Daniel Griffin

July 30, 2022

In his weekly clinical update Dr. Griffin discusses monkeypox virus infection in humans across 16 countries, pregnancy outcomes after SARS-CoV-2 infection by trimester, vaccination intent and belief, antiviral drug treatment for non-severe disease, the association of smoking with infected hospitalized patients, the association of Paxlovid on negative conversion rates among high-risk patients with COVID-19, safety and efficacy of Molnupiravir, usage of enoxaparin for primary thromboprophylaxis, statin and aspirin as therapy in infected patients, post-COVID-19 conditions among children 90 days after SARS-CoV-2 Infection, and symptoms and risk factors for long COVID in non-hospitalized adults.

Click arrow to play
Download TWiV 922 (25 MB .mp3, 42 min)
Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

One comment on “TWiV 922: TWiV clinical update with Dr. Daniel Griffin

  1. Hearing loss can be seen after acute covid infection. I have a patient who lost hearing in one ear after acute covid infection. She had partial hearing loss and the loss became more profound after a second covid infection one year later.